Shaleem I. Jacob

Shaleem I. Jacob

Auto-generated profile, based on publicly available information

Shaleem I. Jacob

Department of Biochemical Engineering, University College London, London, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2013 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
GKGraziella El Khoury
Graziella El Khoury
YWYian Wang
Yian Wang
DWDi Wang
Di Wang
SJShaleem I. Jacob
Shaleem I. Jacob
CLChristopher R. Lowe
Christopher R. Lowe

21 December 2022 in Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
JHJohn M. Hickey
John M. Hickey
SJShaleem I. Jacob
Shaleem I. Jacob
ATAndrew S. Tait
Andrew S. Tait
FVFatemeh Dastjerdi Vahid
Fatemeh Dastjerdi Vahid
JBJoseph Barritt
Joseph Barritt
Daniel G. BracewellDaniel G. Bracewell
Daniel G. Bracewell
Adenovirus vectors have become an important class of vaccines with the recent approval of Ebola and COVID-19 products. In-process quality attribute data collected during Adenovirus vector manufacturing has focused on particle concentration and infectivity ratios (based on viral genome: cell-based infectivity), and data suggest only a fraction of viral particles present in the final vaccine product are efficacious. To better understand this product heterogeneity, lab-scale preparations of two Adenovirus viral vectors, (Chimpanzee adenovirus (ChAdOx1) and Human adenovirus Type 5 (Ad5), were studied using transmission electron microscopy (TEM). Different adenovirus morphologies were characterized, and the proportion of empty and full viral particles were quantified. These proportions showed a qualitative correlation with the sample's infectivity values. Liquid chromatography-mass spectrometry (LC-MS) peptide mapping was used to identify key adenovirus proteins involved in viral maturation. Using peptide abundance analysis, a ∼5-fold change in L1 52/55k abundance was observed between low-(empty) and high-density (full) fractions taken from CsCl ultracentrifugation preparations of ChAdOx1 virus. The L1 52/55k viral protein is associated with DNA packaging and is cleaved during viral maturation, so it may be a marker for infective particles. TEM and LC-MS peptide mapping are promising higher-resolution analytical characterization tools to help differentiate between relative proportions of empty, non-infectious, and infectious viral particles as part of Adenovirus vector in-process monitoring, and these results are an encouraging initial step to better differentiate between the different product-related impurities.

21 June 2017 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
SJShaleem I. Jacob
Shaleem I. Jacob
BKBasmah Khogeer
Basmah Khogeer
NBNick Bampos
Nick Bampos
TSTom Sheppard
Tom Sheppard
RSRichard Schwartz
Richard Schwartz
CLChristopher R. Lowe
Christopher R. Lowe